RMD - ResMed - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

RMD is currently covered by 11 analysts with an average price target of $202.3. This is a potential upside of $17.44 (9.43%) from yesterday's end of day stock price of $184.86.

ResMed's activity chart (see below) currently has 78 price targets and 96 ratings on display. The stock rating distribution of RMD is 75.61% BUY and 24.39% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 53.04% with an average time for these price targets to be met of 96.31 days.

Highest price target for RMD is $260, Lowest price target is $164, average price target is $202.3.

Most recent stock forecast was given by MIKE MATSON from NEEDHAM on 01-Apr-2024.

Split History since 2000:

8/31/10 2 for 1

10/3/05 2 for 1

4/3/00 2 for 1

Currently out of the existing stock ratings of RMD, 31 are a BUY (75.61%), 10 are a HOLD (24.39%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

224

$36.24 (19.30%)

215

19 days ago

5/7 (71.43%)

$34.68 (18.32%)

371

Buy

215

$27.24 (14.51%)

215

24 days ago

7/11 (63.64%)

$18.67 (9.51%)

66

Buy

205

$17.24 (9.18%)

185

2 months 21 days ago

5/11 (45.45%)

$14.1 (7.39%)

88

164

$-23.76 (-12.65%)

158

2 months 26 days ago

4/6 (66.67%)

$-21.88 (-11.77%)

30

Buy

207

$19.24 (10.25%)

2 months 26 days ago

4/5 (80%)

$21.12 (11.36%)

60

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RMD (ResMed) average time for price targets to be met?

On average it took 96.31 days on average for the stock forecasts to be realized with a an average price target met ratio 53.04

Which analyst has the current highest performing score on RMD (ResMed) with a proven track record?

SURAJ KALIA

Which analyst has the most public recommendations on RMD (ResMed)?

Suraj Kalia works at OPPENHEIMER and has 4 price targets and 1 ratings on RMD

Which analyst is the currently most bullish on RMD (ResMed)?

Matthew Mishan with highest potential upside - $72.24

Which analyst is the currently most reserved on RMD (ResMed)?

Matt O'brien with lowest potential downside - -$87.2

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?